Cargando…
Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
Zonisamide (ZNS; 1,2-benzisoxazole-3-methanesulfonamide) was initially developed and is commonly used as an anticonvulsant drug. However, it has also shown its beneficial effects on Parkinson's disease (PD), a progressive neurodegenerative disorder caused by the loss of dopaminergic neurons in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333504/ https://www.ncbi.nlm.nih.gov/pubmed/37441679 http://dx.doi.org/10.3389/fnagi.2023.1221341 |